

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | DNA deamination (GO:0045006) | 9.32779879 |
| 2 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 9.19330173 |
| 3 | regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091 | 8.42815087 |
| 4 | regulation of activation of Janus kinase activity (GO:0010533) | 5.55318668 |
| 5 | positive thymic T cell selection (GO:0045059) | 4.85841374 |
| 6 | positive T cell selection (GO:0043368) | 4.83934383 |
| 7 | negative regulation by host of viral transcription (GO:0043922) | 4.74054110 |
| 8 | pyrimidine nucleoside catabolic process (GO:0046135) | 4.65994547 |
| 9 | positive regulation of interleukin-8 secretion (GO:2000484) | 4.48593217 |
| 10 | eosinophil chemotaxis (GO:0048245) | 4.32299323 |
| 11 | maturation of SSU-rRNA (GO:0030490) | 4.17891778 |
| 12 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 4.02422478 |
| 13 | eosinophil migration (GO:0072677) | 3.91288861 |
| 14 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 3.85015944 |
| 15 | ATP synthesis coupled proton transport (GO:0015986) | 3.85015944 |
| 16 | positive regulation of calcium-mediated signaling (GO:0050850) | 3.83870553 |
| 17 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.77280027 |
| 18 | ribosomal small subunit assembly (GO:0000028) | 3.72279846 |
| 19 | negative T cell selection (GO:0043383) | 3.68920347 |
| 20 | T cell migration (GO:0072678) | 3.68522064 |
| 21 | negative regulation of T cell apoptotic process (GO:0070233) | 3.66882279 |
| 22 | DNA demethylation (GO:0080111) | 3.63811688 |
| 23 | regulation of interleukin-8 secretion (GO:2000482) | 3.61528020 |
| 24 | regulation of regulatory T cell differentiation (GO:0045589) | 3.59616035 |
| 25 | chaperone-mediated protein transport (GO:0072321) | 3.53227777 |
| 26 | negative regulation of viral genome replication (GO:0045071) | 3.52749762 |
| 27 | positive regulation of defense response to virus by host (GO:0002230) | 3.51957278 |
| 28 | negative regulation of mast cell activation (GO:0033004) | 3.51095171 |
| 29 | regulation of T cell receptor signaling pathway (GO:0050856) | 3.50339254 |
| 30 | actin nucleation (GO:0045010) | 3.50054831 |
| 31 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.49178486 |
| 32 | macrophage chemotaxis (GO:0048246) | 3.47600880 |
| 33 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.43954753 |
| 34 | cellular response to interleukin-15 (GO:0071350) | 3.43748482 |
| 35 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 3.42768199 |
| 36 | regulation of lymphocyte chemotaxis (GO:1901623) | 3.37643979 |
| 37 | DNA dealkylation (GO:0035510) | 3.36469365 |
| 38 | thymic T cell selection (GO:0045061) | 3.32298779 |
| 39 | metallo-sulfur cluster assembly (GO:0031163) | 3.31089462 |
| 40 | iron-sulfur cluster assembly (GO:0016226) | 3.31089462 |
| 41 | cytolysis (GO:0019835) | 3.30237530 |
| 42 | regulation of chronic inflammatory response (GO:0002676) | 3.30185657 |
| 43 | protein neddylation (GO:0045116) | 3.28805946 |
| 44 | ribosomal small subunit biogenesis (GO:0042274) | 3.27992306 |
| 45 | pyrimidine-containing compound catabolic process (GO:0072529) | 3.23831929 |
| 46 | negative regulation of B cell proliferation (GO:0030889) | 3.23803393 |
| 47 | positive regulation of T cell apoptotic process (GO:0070234) | 3.23688532 |
| 48 | positive regulation of phosphoprotein phosphatase activity (GO:0032516) | 3.23390051 |
| 49 | positive regulation of lymphocyte migration (GO:2000403) | 3.21877339 |
| 50 | respiratory electron transport chain (GO:0022904) | 3.18848372 |
| 51 | positive regulation of tolerance induction (GO:0002645) | 3.18354914 |
| 52 | sequestering of actin monomers (GO:0042989) | 3.15769922 |
| 53 | electron transport chain (GO:0022900) | 3.15122989 |
| 54 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.13461338 |
| 55 | pyrimidine ribonucleoside metabolic process (GO:0046131) | 3.05690083 |
| 56 | negative regulation of antigen receptor-mediated signaling pathway (GO:0050858) | 3.05621324 |
| 57 | negative regulation of lymphocyte apoptotic process (GO:0070229) | 3.05019327 |
| 58 | positive regulation of leukocyte mediated cytotoxicity (GO:0001912) | 3.04277014 |
| 59 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 3.04011066 |
| 60 | regulation of T cell tolerance induction (GO:0002664) | 2.98656362 |
| 61 | regulation of T cell mediated cytotoxicity (GO:0001914) | 2.98537796 |
| 62 | T cell costimulation (GO:0031295) | 2.98146254 |
| 63 | positive regulation of natural killer cell mediated immunity (GO:0002717) | 2.96865667 |
| 64 | T cell selection (GO:0045058) | 2.96750053 |
| 65 | regulation of leukocyte mediated cytotoxicity (GO:0001910) | 2.95350260 |
| 66 | viral transcription (GO:0019083) | 2.95109838 |
| 67 | lymphocyte costimulation (GO:0031294) | 2.94500341 |
| 68 | positive regulation of natural killer cell mediated cytotoxicity (GO:0045954) | 2.94437882 |
| 69 | positive regulation of B cell differentiation (GO:0045579) | 2.94244278 |
| 70 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 2.91242865 |
| 71 | T cell receptor signaling pathway (GO:0050852) | 2.88349877 |
| 72 | positive regulation of T cell chemotaxis (GO:0010820) | 2.85644022 |
| 73 | regulation of T cell chemotaxis (GO:0010819) | 2.85644022 |
| 74 | response to gravity (GO:0009629) | 2.85074406 |
| 75 | establishment of protein localization to mitochondrial membrane (GO:0090151) | 2.84825996 |
| 76 | protein complex biogenesis (GO:0070271) | 2.84587591 |
| 77 | regulation of natural killer cell mediated immunity (GO:0002715) | 2.83408188 |
| 78 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 2.83408188 |
| 79 | response to interleukin-15 (GO:0070672) | 2.80887113 |
| 80 | translational termination (GO:0006415) | 2.80862635 |
| 81 | positive regulation of gamma-delta T cell activation (GO:0046645) | 2.77491064 |
| 82 | proteasome assembly (GO:0043248) | 2.75101675 |
| 83 | positive regulation of cell killing (GO:0031343) | 2.73900162 |
| 84 | regulation of calcium-mediated signaling (GO:0050848) | 2.72982066 |
| 85 | translational elongation (GO:0006414) | 2.70852458 |
| 86 | regulation of cell killing (GO:0031341) | 2.70221462 |
| 87 | water-soluble vitamin biosynthetic process (GO:0042364) | 2.69398564 |
| 88 | negative thymic T cell selection (GO:0045060) | 2.69237084 |
| 89 | positive regulation of translational initiation (GO:0045948) | 2.65600359 |
| 90 | nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291) | 2.62809699 |
| 91 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 2.62219601 |
| 92 | regulation of T cell apoptotic process (GO:0070232) | 2.61282763 |
| 93 | regulation of B cell differentiation (GO:0045577) | 2.59942685 |
| 94 | regulation of cellular amino acid metabolic process (GO:0006521) | 2.59673780 |
| 95 | platelet dense granule organization (GO:0060155) | 2.58748960 |
| 96 | negative regulation of cell killing (GO:0031342) | 2.58592448 |
| 97 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.58592448 |
| 98 | cytidine metabolic process (GO:0046087) | 10.4755584 |
| 99 | cytidine catabolic process (GO:0006216) | 10.4755584 |
| 100 | cytidine deamination (GO:0009972) | 10.4755584 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 7.66483659 |
| 2 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 5.19686352 |
| 3 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 4.24723234 |
| 4 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 3.52424980 |
| 5 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 3.17383696 |
| 6 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.16372394 |
| 7 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.99221399 |
| 8 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 2.78603610 |
| 9 | VDR_22108803_ChIP-Seq_LS180_Human | 2.73482476 |
| 10 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 2.66369641 |
| 11 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 2.57394901 |
| 12 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 2.25636457 |
| 13 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.24485326 |
| 14 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.21835103 |
| 15 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 2.19578451 |
| 16 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 2.18907151 |
| 17 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 2.18015626 |
| 18 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.93497591 |
| 19 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.88095045 |
| 20 | MYB_26560356_Chip-Seq_TH2_Human | 1.79464828 |
| 21 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.74432391 |
| 22 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.72651713 |
| 23 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.72212880 |
| 24 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.70814806 |
| 25 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.69375078 |
| 26 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.65903068 |
| 27 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.65698322 |
| 28 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.63448517 |
| 29 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.61076729 |
| 30 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.60907800 |
| 31 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.60116702 |
| 32 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.59082988 |
| 33 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.54655853 |
| 34 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.51788245 |
| 35 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.49294865 |
| 36 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.48515412 |
| 37 | GATA3_26560356_Chip-Seq_TH2_Human | 1.45611744 |
| 38 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.44699867 |
| 39 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.43084316 |
| 40 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.42489810 |
| 41 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.41303231 |
| 42 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.39116341 |
| 43 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 1.38366807 |
| 44 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.34980585 |
| 45 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.32086389 |
| 46 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 1.30109801 |
| 47 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.28659064 |
| 48 | RBPJ_21746931_ChIP-Seq_IB4-LCL_Human | 1.28537853 |
| 49 | TAF2_19829295_ChIP-Seq_ESCs_Human | 1.25535321 |
| 50 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.23263227 |
| 51 | NANOG_20526341_ChIP-Seq_ESCs_Human | 1.20469876 |
| 52 | TAL1_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.20170527 |
| 53 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 1.19676917 |
| 54 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.18969089 |
| 55 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.18951198 |
| 56 | MYC_18940864_ChIP-ChIP_HL60_Human | 1.18370297 |
| 57 | NCOR_22424771_ChIP-Seq_293T_Human | 1.15244835 |
| 58 | AR_20517297_ChIP-Seq_VCAP_Human | 1.15156509 |
| 59 | MYB_26560356_Chip-Seq_TH1_Human | 1.14575259 |
| 60 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.13711635 |
| 61 | PAX6_23342162_ChIP-ChIP_BETA-FORBRAIN-LENS_Mouse | 1.09426203 |
| 62 | UTX_26944678_Chip-Seq_JUKART_Human | 1.09300593 |
| 63 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.07361645 |
| 64 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.03379103 |
| 65 | STAT1_20625510_ChIP-Seq_HELA_Human | 1.01167056 |
| 66 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.00481876 |
| 67 | P300_27268052_Chip-Seq_Bcells_Human | 1.00335319 |
| 68 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 0.99669110 |
| 69 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 0.98696607 |
| 70 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 0.97328962 |
| 71 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 0.96934025 |
| 72 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 0.96652962 |
| 73 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 0.96463249 |
| 74 | SOX2_19829295_ChIP-Seq_ESCs_Human | 0.95702051 |
| 75 | NANOG_19829295_ChIP-Seq_ESCs_Human | 0.95702051 |
| 76 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 0.95084494 |
| 77 | MAF_26560356_Chip-Seq_TH2_Human | 0.95071740 |
| 78 | TAF15_26573619_Chip-Seq_HEK293_Human | 0.94884053 |
| 79 | CEBPA_26348894_ChIP-Seq_LIVER_Mouse | 0.93876306 |
| 80 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 0.93855725 |
| 81 | EBNA1_20929547_Chip-Seq_RAJI-cells_Human | 0.93815235 |
| 82 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.93648758 |
| 83 | FOXH1_21741376_ChIP-Seq_EPCs_Human | 0.92305629 |
| 84 | CTCF_20526341_ChIP-Seq_ESCs_Human | 0.91985145 |
| 85 | GATA6_21074721_ChIP-Seq_CACO-2_Mouse | 0.91204358 |
| 86 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 0.90620051 |
| 87 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 0.90620051 |
| 88 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 0.90179781 |
| 89 | ERG_20517297_ChIP-Seq_VCAP_Human | 0.89147090 |
| 90 | MYC_19829295_ChIP-Seq_ESCs_Human | 0.88687867 |
| 91 | GATA3_21878914_ChIP-Seq_MCF-7_Human | 0.88373979 |
| 92 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.88092259 |
| 93 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 0.86789635 |
| 94 | ERA_21632823_ChIP-Seq_H3396_Human | 0.86561189 |
| 95 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.85935303 |
| 96 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 0.85599292 |
| 97 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 0.85227809 |
| 98 | CIITA_25753668_ChIP-Seq_RAJI_Human | 0.85014192 |
| 99 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.85013732 |
| 100 | GATA3_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.84545521 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005671_abnormal_response_to | 5.75686742 |
| 2 | MP0009333_abnormal_splenocyte_physiolog | 3.55556168 |
| 3 | MP0004145_abnormal_muscle_electrophysio | 3.14451780 |
| 4 | MP0003763_abnormal_thymus_physiology | 2.92247288 |
| 5 | MP0009379_abnormal_foot_pigmentation | 2.88737301 |
| 6 | MP0009785_altered_susceptibility_to | 2.74332225 |
| 7 | MP0001835_abnormal_antigen_presentation | 2.67930727 |
| 8 | MP0002148_abnormal_hypersensitivity_rea | 2.53859231 |
| 9 | MP0003786_premature_aging | 2.34375201 |
| 10 | MP0006082_CNS_inflammation | 2.28562141 |
| 11 | MP0005000_abnormal_immune_tolerance | 2.27905508 |
| 12 | MP0002723_abnormal_immune_serum | 2.12699014 |
| 13 | MP0002420_abnormal_adaptive_immunity | 2.11377147 |
| 14 | MP0001819_abnormal_immune_cell | 2.05995850 |
| 15 | MP0001800_abnormal_humoral_immune | 2.05947983 |
| 16 | MP0003646_muscle_fatigue | 2.02994495 |
| 17 | MP0005025_abnormal_response_to | 2.01557886 |
| 18 | MP0002163_abnormal_gland_morphology | 2.01525465 |
| 19 | MP0002138_abnormal_hepatobiliary_system | 1.95131109 |
| 20 | MP0003806_abnormal_nucleotide_metabolis | 1.88679174 |
| 21 | MP0001790_abnormal_immune_system | 1.81722846 |
| 22 | MP0005387_immune_system_phenotype | 1.81722846 |
| 23 | MP0003866_abnormal_defecation | 1.72227344 |
| 24 | MP0000372_irregular_coat_pigmentation | 1.71091561 |
| 25 | MP0002452_abnormal_antigen_presenting | 1.68022215 |
| 26 | MP0005389_reproductive_system_phenotype | 1.62672138 |
| 27 | MP0000716_abnormal_immune_system | 1.62345408 |
| 28 | MP0002102_abnormal_ear_morphology | 1.59698130 |
| 29 | MP0001919_abnormal_reproductive_system | 1.58689318 |
| 30 | MP0001661_extended_life_span | 1.49455809 |
| 31 | MP0002398_abnormal_bone_marrow | 1.48428859 |
| 32 | MP0000703_abnormal_thymus_morphology | 1.44620597 |
| 33 | MP0002876_abnormal_thyroid_physiology | 1.44367860 |
| 34 | MP0000685_abnormal_immune_system | 1.43606216 |
| 35 | MP0001905_abnormal_dopamine_level | 1.41938645 |
| 36 | MP0001873_stomach_inflammation | 1.40221160 |
| 37 | MP0005645_abnormal_hypothalamus_physiol | 1.39622529 |
| 38 | MP0008872_abnormal_physiological_respon | 1.35698006 |
| 39 | MP0005083_abnormal_biliary_tract | 1.34544112 |
| 40 | MP0005379_endocrine/exocrine_gland_phen | 1.33455654 |
| 41 | MP0002166_altered_tumor_susceptibility | 1.32763345 |
| 42 | MP0001485_abnormal_pinna_reflex | 1.32423843 |
| 43 | MP0002722_abnormal_immune_system | 1.31298947 |
| 44 | MP0001968_abnormal_touch/_nociception | 1.29696391 |
| 45 | MP0003878_abnormal_ear_physiology | 1.28693739 |
| 46 | MP0005377_hearing/vestibular/ear_phenot | 1.28693739 |
| 47 | MP0006036_abnormal_mitochondrial_physio | 1.28212433 |
| 48 | MP0001188_hyperpigmentation | 1.26205248 |
| 49 | MP0002419_abnormal_innate_immunity | 1.25526536 |
| 50 | MP0002160_abnormal_reproductive_system | 1.23560379 |
| 51 | MP0010155_abnormal_intestine_physiology | 1.22755320 |
| 52 | MP0002405_respiratory_system_inflammati | 1.22230160 |
| 53 | MP0002277_abnormal_respiratory_mucosa | 1.20596640 |
| 54 | MP0002429_abnormal_blood_cell | 1.20561876 |
| 55 | MP0010307_abnormal_tumor_latency | 1.20350568 |
| 56 | MP0005075_abnormal_melanosome_morpholog | 1.20072955 |
| 57 | MP0004036_abnormal_muscle_relaxation | 1.18838284 |
| 58 | MP0005646_abnormal_pituitary_gland | 1.18107194 |
| 59 | MP0002837_dystrophic_cardiac_calcinosis | 1.18037399 |
| 60 | MP0002095_abnormal_skin_pigmentation | 1.16673551 |
| 61 | MP0005410_abnormal_fertilization | 1.16267185 |
| 62 | MP0006072_abnormal_retinal_apoptosis | 1.13748980 |
| 63 | MP0001845_abnormal_inflammatory_respons | 1.13127088 |
| 64 | MP0000689_abnormal_spleen_morphology | 1.10462627 |
| 65 | MP0003045_fibrosis | 1.09921169 |
| 66 | MP0002006_tumorigenesis | 1.03153367 |
| 67 | MP0008469_abnormal_protein_level | 0.99380300 |
| 68 | MP0009764_decreased_sensitivity_to | 0.99010655 |
| 69 | MP0006276_abnormal_autonomic_nervous | 0.98784956 |
| 70 | MP0004147_increased_porphyrin_level | 0.98659467 |
| 71 | MP0002736_abnormal_nociception_after | 0.93523922 |
| 72 | MP0005551_abnormal_eye_electrophysiolog | 0.93153861 |
| 73 | MP0002269_muscular_atrophy | 0.92404979 |
| 74 | MP0008873_increased_physiological_sensi | 0.91881321 |
| 75 | MP0003137_abnormal_impulse_conducting | 0.90891423 |
| 76 | MP0008875_abnormal_xenobiotic_pharmacok | 0.88766324 |
| 77 | MP0003448_altered_tumor_morphology | 0.87704419 |
| 78 | MP0000749_muscle_degeneration | 0.87500252 |
| 79 | MP0005084_abnormal_gallbladder_morpholo | 0.86998390 |
| 80 | MP0009763_increased_sensitivity_to | 0.85751629 |
| 81 | MP0003252_abnormal_bile_duct | 0.82464864 |
| 82 | MP0009765_abnormal_xenobiotic_induced | 0.82318096 |
| 83 | MP0005166_decreased_susceptibility_to | 0.80998262 |
| 84 | MP0009745_abnormal_behavioral_response | 0.80530493 |
| 85 | MP0002693_abnormal_pancreas_physiology | 0.79680537 |
| 86 | MP0005174_abnormal_tail_pigmentation | 0.77815480 |
| 87 | MP0002933_joint_inflammation | 0.77367612 |
| 88 | MP0001765_abnormal_ion_homeostasis | 0.76812291 |
| 89 | MP0004043_abnormal_pH_regulation | 0.76612835 |
| 90 | MP0003436_decreased_susceptibility_to | 0.74885058 |
| 91 | MP0005636_abnormal_mineral_homeostasis | 0.74330661 |
| 92 | MP0004381_abnormal_hair_follicle | 0.72803950 |
| 93 | MP0008007_abnormal_cellular_replicative | 0.72800697 |
| 94 | MP0002733_abnormal_thermal_nociception | 0.72401688 |
| 95 | MP0006292_abnormal_olfactory_placode | 0.71545098 |
| 96 | MP0005253_abnormal_eye_physiology | 0.70653474 |
| 97 | MP0002638_abnormal_pupillary_reflex | 0.67908840 |
| 98 | MP0004142_abnormal_muscle_tone | 0.67814870 |
| 99 | MP0003011_delayed_dark_adaptation | 0.66378079 |
| 100 | MP0003195_calcinosis | 0.64975440 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | 3-Methylglutaconic aciduria (HP:0003535) | 5.27257878 |
| 2 | Acute necrotizing encephalopathy (HP:0006965) | 4.24632044 |
| 3 | Abnormality of T cell number (HP:0011839) | 4.22765472 |
| 4 | T lymphocytopenia (HP:0005403) | 4.21095429 |
| 5 | Abnormal mitochondria in muscle tissue (HP:0008316) | 4.04365116 |
| 6 | Aplastic anemia (HP:0001915) | 3.84647170 |
| 7 | Mitochondrial inheritance (HP:0001427) | 3.80363081 |
| 8 | Hypoproteinemia (HP:0003075) | 3.74015051 |
| 9 | Autoimmune hemolytic anemia (HP:0001890) | 3.72818954 |
| 10 | Progressive macrocephaly (HP:0004481) | 3.51777005 |
| 11 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 3.39390429 |
| 12 | IgG deficiency (HP:0004315) | 3.30807146 |
| 13 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 3.30398856 |
| 14 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 3.30398856 |
| 15 | Increased CSF lactate (HP:0002490) | 3.28912739 |
| 16 | Severe combined immunodeficiency (HP:0004430) | 3.27297716 |
| 17 | Acute encephalopathy (HP:0006846) | 3.26841837 |
| 18 | Hepatocellular necrosis (HP:0001404) | 3.03224742 |
| 19 | Abnormality of the prostate (HP:0008775) | 3.02081071 |
| 20 | Abnormality of T cells (HP:0002843) | 3.01416991 |
| 21 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.92751057 |
| 22 | Abolished electroretinogram (ERG) (HP:0000550) | 2.88906556 |
| 23 | Congenital stationary night blindness (HP:0007642) | 2.84398555 |
| 24 | Hepatic necrosis (HP:0002605) | 2.82744943 |
| 25 | Abnormality of eosinophils (HP:0001879) | 2.78612207 |
| 26 | Cerebral edema (HP:0002181) | 2.70160825 |
| 27 | Abnormality of B cell number (HP:0010975) | 2.65593519 |
| 28 | Absent phalangeal crease (HP:0006109) | 2.63826264 |
| 29 | Fibular aplasia (HP:0002990) | 2.61139046 |
| 30 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 2.60273208 |
| 31 | Abnormal rod and cone electroretinograms (HP:0008323) | 2.54077428 |
| 32 | Eosinophilia (HP:0001880) | 2.53368458 |
| 33 | Thyroiditis (HP:0100646) | 2.51699844 |
| 34 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 2.50738235 |
| 35 | Abnormality of alanine metabolism (HP:0010916) | 2.50738235 |
| 36 | Hyperalaninemia (HP:0003348) | 2.50738235 |
| 37 | Ureteral stenosis (HP:0000071) | 2.50516971 |
| 38 | Renal cortical cysts (HP:0000803) | 2.48780050 |
| 39 | Palpebral edema (HP:0100540) | 2.48736775 |
| 40 | Severe visual impairment (HP:0001141) | 2.45939376 |
| 41 | Increased serum lactate (HP:0002151) | 2.45699032 |
| 42 | Gastrointestinal infarctions (HP:0005244) | 2.45459284 |
| 43 | Combined immunodeficiency (HP:0005387) | 2.43456867 |
| 44 | Pancreatic cysts (HP:0001737) | 2.42296185 |
| 45 | Increased intramyocellular lipid droplets (HP:0012240) | 2.41610565 |
| 46 | Periorbital edema (HP:0100539) | 2.38568925 |
| 47 | Colon cancer (HP:0003003) | 2.35684493 |
| 48 | Optic disc pallor (HP:0000543) | 2.33168013 |
| 49 | Pendular nystagmus (HP:0012043) | 2.33110849 |
| 50 | Ureteral obstruction (HP:0006000) | 2.32932746 |
| 51 | Abnormal albumin level (HP:0012116) | 2.29831394 |
| 52 | Hypoalbuminemia (HP:0003073) | 2.29831394 |
| 53 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.29631620 |
| 54 | Chronic diarrhea (HP:0002028) | 2.28238678 |
| 55 | Abnormality of the renal cortex (HP:0011035) | 2.25030808 |
| 56 | Radial bowing (HP:0002986) | 2.23950267 |
| 57 | Facial edema (HP:0000282) | 2.23041458 |
| 58 | B lymphocytopenia (HP:0010976) | 2.22003906 |
| 59 | Attenuation of retinal blood vessels (HP:0007843) | 2.20661746 |
| 60 | Lactic acidosis (HP:0003128) | 2.20231116 |
| 61 | Symphalangism affecting the phalanges of the hand (HP:0009773) | 2.19474848 |
| 62 | Abnormality of the phalanges of the 2nd finger (HP:0009541) | 2.14960202 |
| 63 | Abnormality of the middle phalanx of the 5th finger (HP:0004219) | 2.13764989 |
| 64 | Abnormal finger flexion creases (HP:0006143) | 2.12631741 |
| 65 | Nemaline bodies (HP:0003798) | 2.12283532 |
| 66 | Distal arthrogryposis (HP:0005684) | 2.12196123 |
| 67 | Autoimmune thrombocytopenia (HP:0001973) | 2.09556552 |
| 68 | Microretrognathia (HP:0000308) | 2.07047644 |
| 69 | Exercise intolerance (HP:0003546) | 2.02307704 |
| 70 | Increased muscle lipid content (HP:0009058) | 2.01632644 |
| 71 | Respiratory failure (HP:0002878) | 2.01594011 |
| 72 | Abnormality of the phalanges of the 5th finger (HP:0004213) | 1.97580840 |
| 73 | Leukocytosis (HP:0001974) | 1.96721449 |
| 74 | Stomatitis (HP:0010280) | 1.95983373 |
| 75 | Constricted visual fields (HP:0001133) | 1.92953547 |
| 76 | Granulocytopenia (HP:0001913) | 1.92101439 |
| 77 | Gangrene (HP:0100758) | 1.90648207 |
| 78 | Abnormality of midbrain morphology (HP:0002418) | 1.90212695 |
| 79 | Molar tooth sign on MRI (HP:0002419) | 1.90212695 |
| 80 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 1.89495675 |
| 81 | Increased IgM level (HP:0003496) | 1.88571527 |
| 82 | Encephalitis (HP:0002383) | 1.87585406 |
| 83 | Chest pain (HP:0100749) | 1.86772741 |
| 84 | Delayed CNS myelination (HP:0002188) | 1.85561143 |
| 85 | Recurrent bronchitis (HP:0002837) | 1.84424120 |
| 86 | Carpal bone hypoplasia (HP:0001498) | 1.83366215 |
| 87 | Lethargy (HP:0001254) | 1.81142966 |
| 88 | Pulmonary fibrosis (HP:0002206) | 1.79954997 |
| 89 | Abnormality of the middle phalanges of the toes (HP:0010183) | 1.78168540 |
| 90 | Abnormality of T cell physiology (HP:0011840) | 1.76717761 |
| 91 | Lymphopenia (HP:0001888) | 1.76709927 |
| 92 | Adactyly (HP:0009776) | 1.75603468 |
| 93 | Pigmentary retinal degeneration (HP:0001146) | 1.75182521 |
| 94 | Chronic obstructive pulmonary disease (HP:0006510) | 1.74546563 |
| 95 | Obstructive lung disease (HP:0006536) | 1.74546563 |
| 96 | Abnormality of the proximal phalanges of the hand (HP:0009834) | 1.74480269 |
| 97 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 1.74295340 |
| 98 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 1.72600618 |
| 99 | Aplasia/hypoplasia of the uterus (HP:0008684) | 1.71237455 |
| 100 | Type I transferrin isoform profile (HP:0003642) | 1.70751695 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TXK | 5.37191171 |
| 2 | KDR | 4.97687153 |
| 3 | TESK2 | 3.54530065 |
| 4 | BUB1 | 3.39164756 |
| 5 | BCKDK | 2.80757099 |
| 6 | LIMK1 | 2.51253494 |
| 7 | MAP4K1 | 2.46572695 |
| 8 | STK16 | 2.43900011 |
| 9 | TLK1 | 2.43882261 |
| 10 | ADRBK2 | 2.41561907 |
| 11 | VRK2 | 2.17903330 |
| 12 | TIE1 | 2.17342287 |
| 13 | SCYL2 | 2.15760443 |
| 14 | ITK | 2.01501587 |
| 15 | TAOK3 | 1.98785702 |
| 16 | MAP4K2 | 1.94073740 |
| 17 | MUSK | 1.92142627 |
| 18 | ZAK | 1.86867456 |
| 19 | NUAK1 | 1.77760844 |
| 20 | FES | 1.69990017 |
| 21 | MAP3K12 | 1.61996028 |
| 22 | GRK1 | 1.59706062 |
| 23 | PIK3CA | 1.54064228 |
| 24 | WNK4 | 1.52505407 |
| 25 | PRKCQ | 1.40370049 |
| 26 | OBSCN | 1.36127716 |
| 27 | GRK6 | 1.31696337 |
| 28 | MST4 | 1.29295911 |
| 29 | SYK | 1.26350924 |
| 30 | PHKG2 | 1.19667291 |
| 31 | PHKG1 | 1.19667291 |
| 32 | CSK | 1.18321528 |
| 33 | FRK | 1.11829443 |
| 34 | IKBKB | 1.07797675 |
| 35 | TESK1 | 1.07140120 |
| 36 | JAK3 | 1.05082521 |
| 37 | LCK | 1.04341715 |
| 38 | PIK3CG | 1.04148073 |
| 39 | SRPK1 | 1.00975359 |
| 40 | MAP3K11 | 0.99242174 |
| 41 | VRK1 | 0.96825744 |
| 42 | IKBKE | 0.94314934 |
| 43 | ZAP70 | 0.89136240 |
| 44 | BMPR1B | 0.86128378 |
| 45 | RIPK4 | 0.83239566 |
| 46 | BTK | 0.82545581 |
| 47 | EIF2AK3 | 0.81838137 |
| 48 | GRK7 | 0.80971514 |
| 49 | PASK | 0.79526146 |
| 50 | DAPK1 | 0.79358404 |
| 51 | TEC | 0.78539326 |
| 52 | LYN | 0.78483008 |
| 53 | PIM2 | 0.76687643 |
| 54 | BLK | 0.72843736 |
| 55 | MYLK | 0.70656043 |
| 56 | INSRR | 0.70497131 |
| 57 | RPS6KA5 | 0.67946212 |
| 58 | AURKA | 0.66871320 |
| 59 | CAMKK2 | 0.66784724 |
| 60 | TYRO3 | 0.65296111 |
| 61 | MATK | 0.65266387 |
| 62 | DAPK2 | 0.64753101 |
| 63 | TBK1 | 0.62942836 |
| 64 | PINK1 | 0.61022542 |
| 65 | ADRBK1 | 0.57510643 |
| 66 | DYRK2 | 0.52695629 |
| 67 | CSF1R | 0.50426578 |
| 68 | BMPR2 | 0.49996144 |
| 69 | NEK1 | 0.49137464 |
| 70 | OXSR1 | 0.47425677 |
| 71 | CCNB1 | 0.46528936 |
| 72 | ARAF | 0.44239712 |
| 73 | TAF1 | 0.42766605 |
| 74 | MAPK13 | 0.41231827 |
| 75 | ATR | 0.40270453 |
| 76 | CSNK1G3 | 0.40161670 |
| 77 | FYN | 0.39792909 |
| 78 | PRKCA | 0.39354034 |
| 79 | CAMKK1 | 0.39028900 |
| 80 | IGF1R | 0.38989166 |
| 81 | PLK4 | 0.38715017 |
| 82 | PIM1 | 0.38293706 |
| 83 | MARK3 | 0.36693871 |
| 84 | PRKACA | 0.35886348 |
| 85 | CHEK2 | 0.35174462 |
| 86 | CDK4 | 0.35157815 |
| 87 | KIT | 0.34000413 |
| 88 | CSNK2A1 | 0.32041967 |
| 89 | TNK2 | 0.31608507 |
| 90 | DAPK3 | 0.31389821 |
| 91 | ABL2 | 0.31224055 |
| 92 | GRK5 | 0.30823238 |
| 93 | ROCK1 | 0.29901472 |
| 94 | CDK8 | 0.29486871 |
| 95 | CSNK2A2 | 0.29206134 |
| 96 | MAP2K6 | 0.27612455 |
| 97 | CAMK2G | 0.26888048 |
| 98 | CLK1 | 0.26125608 |
| 99 | PDK2 | 0.25904629 |
| 100 | ILK | 0.24340905 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary immunodeficiency_Homo sapiens_hsa05340 | 4.31731533 |
| 2 | Graft-versus-host disease_Homo sapiens_hsa05332 | 3.87299866 |
| 3 | Proteasome_Homo sapiens_hsa03050 | 3.67685242 |
| 4 | Ribosome_Homo sapiens_hsa03010 | 3.66447174 |
| 5 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 3.36442097 |
| 6 | Allograft rejection_Homo sapiens_hsa05330 | 3.35173140 |
| 7 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 3.30957163 |
| 8 | Antigen processing and presentation_Homo sapiens_hsa04612 | 3.00575653 |
| 9 | Parkinsons disease_Homo sapiens_hsa05012 | 2.84961604 |
| 10 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.68352842 |
| 11 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 2.64122787 |
| 12 | RNA polymerase_Homo sapiens_hsa03020 | 2.27968261 |
| 13 | Asthma_Homo sapiens_hsa05310 | 2.20689542 |
| 14 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.14927215 |
| 15 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 2.11313472 |
| 16 | Alzheimers disease_Homo sapiens_hsa05010 | 1.93651429 |
| 17 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.87410817 |
| 18 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.79610193 |
| 19 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.77439952 |
| 20 | Huntingtons disease_Homo sapiens_hsa05016 | 1.76422991 |
| 21 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.64882546 |
| 22 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.52754865 |
| 23 | Viral myocarditis_Homo sapiens_hsa05416 | 1.39852121 |
| 24 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.37917391 |
| 25 | Protein export_Homo sapiens_hsa03060 | 1.34241020 |
| 26 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.34068289 |
| 27 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.33966791 |
| 28 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.21021626 |
| 29 | Phototransduction_Homo sapiens_hsa04744 | 1.18346168 |
| 30 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.13970130 |
| 31 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.09892627 |
| 32 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 1.05496512 |
| 33 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.04261135 |
| 34 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 1.03322279 |
| 35 | RNA degradation_Homo sapiens_hsa03018 | 0.99289823 |
| 36 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.97775262 |
| 37 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.92410238 |
| 38 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.86245386 |
| 39 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.84964872 |
| 40 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.83571829 |
| 41 | Measles_Homo sapiens_hsa05162 | 0.82573417 |
| 42 | Purine metabolism_Homo sapiens_hsa00230 | 0.81064255 |
| 43 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.79091068 |
| 44 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.78696681 |
| 45 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.74021826 |
| 46 | Homologous recombination_Homo sapiens_hsa03440 | 0.73021467 |
| 47 | Peroxisome_Homo sapiens_hsa04146 | 0.72374441 |
| 48 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.68166924 |
| 49 | Salmonella infection_Homo sapiens_hsa05132 | 0.66823009 |
| 50 | Spliceosome_Homo sapiens_hsa03040 | 0.62369806 |
| 51 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.60374587 |
| 52 | Malaria_Homo sapiens_hsa05144 | 0.59349690 |
| 53 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.58448139 |
| 54 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.56223699 |
| 55 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.55037522 |
| 56 | Olfactory transduction_Homo sapiens_hsa04740 | 0.53780668 |
| 57 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.53236843 |
| 58 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.52775220 |
| 59 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.52355779 |
| 60 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.51270725 |
| 61 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.50261084 |
| 62 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.47501346 |
| 63 | DNA replication_Homo sapiens_hsa03030 | 0.46661247 |
| 64 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.45540973 |
| 65 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.45178962 |
| 66 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.44804161 |
| 67 | Leishmaniasis_Homo sapiens_hsa05140 | 0.43839964 |
| 68 | Retinol metabolism_Homo sapiens_hsa00830 | 0.43304364 |
| 69 | Base excision repair_Homo sapiens_hsa03410 | 0.41469618 |
| 70 | Shigellosis_Homo sapiens_hsa05131 | 0.40790363 |
| 71 | Nicotine addiction_Homo sapiens_hsa05033 | 0.40182345 |
| 72 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.39086537 |
| 73 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.38985325 |
| 74 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.38498781 |
| 75 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.36429323 |
| 76 | Legionellosis_Homo sapiens_hsa05134 | 0.36314509 |
| 77 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.35301653 |
| 78 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.35275232 |
| 79 | Metabolic pathways_Homo sapiens_hsa01100 | 0.32673947 |
| 80 | HTLV-I infection_Homo sapiens_hsa05166 | 0.32153215 |
| 81 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.31686502 |
| 82 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.30482838 |
| 83 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.29909024 |
| 84 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.29170468 |
| 85 | Morphine addiction_Homo sapiens_hsa05032 | 0.27008311 |
| 86 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.26735358 |
| 87 | Basal transcription factors_Homo sapiens_hsa03022 | 0.23745617 |
| 88 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.23653433 |
| 89 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.22681609 |
| 90 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.22629493 |
| 91 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.20915284 |
| 92 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.19548786 |
| 93 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.19164599 |
| 94 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.18942412 |
| 95 | RNA transport_Homo sapiens_hsa03013 | 0.18617500 |
| 96 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.17214583 |
| 97 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.16811549 |
| 98 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.14700015 |
| 99 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.14041729 |
| 100 | Salivary secretion_Homo sapiens_hsa04970 | 0.14028510 |

